Kartogenin is primarily used in regenerative medicine, particularly in the field of cartilage repair and osteoarthritis treatment. It promotes chondrogenesis, the process by which stem cells differentiate into chondrocytes, the cells responsible for forming cartilage. This makes it a promising compound for developing therapies aimed at repairing damaged joint cartilage. It has been studied for its ability to stimulate mesenchymal stem cells to migrate to damaged cartilage sites and differentiate into functional chondrocytes, helping restore joint function. Due to this property, kartogenin is being explored in intra-articular injections and biomaterial-based delivery systems for localized treatment of joint injuries. In addition to cartilage regeneration, kartogenin shows potential in reducing inflammation and slowing down cartilage degeneration in osteoarthritic joints. Its small molecular size allows for easier formulation and delivery compared to biologics, making it a favorable candidate for drug development in orthopedics and sports medicine.